Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Oct 18, 2024 4:31pm
RE:RE:RE:Re: Moment of Tru
In its recent PR succession plan is put in place - on march 3 2024 I opinioned this seemed to have been a big omission from the merger information documents
(28)
•••
tigerpro
X
View Profile
View Bullboard History
Comment by
tigerpro
on Aug 12, 2024 4:20am
RE:RE:Re: Moment of Tru
Even we know the CEO cheated the big shareholder OATS before the merge vote, the CEO can still keeps the board position. I can not believe this, I dont' know which
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(28)
•••
tigerpro
X
View Profile
View Bullboard History
Comment by
tigerpro
on Aug 12, 2024 4:17am
RE:Re: Moment of Tru
I have sold my shares with big loss. It is my fault to believe a liar CEO. Gagnon will lead the new company to bankruptcy before he steals the last money from the new company.
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 08, 2024 9:05pm
PGX-YBG
Based on average timeline from submission to the journal Biomaterials to publishing the comprehensive article on PGX-YBG/Fibrosis could be published within the next 30 days. In the October Small Cap
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Aug 07, 2024 9:27pm
RE:H.C. Wainwright 26th Annual Global Investment Conference
I don't know if AEZS is presenting or not but...
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 07, 2024 9:24pm
H.C. Wainwright 26th Annual Global Investment Conference
H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 07, 2024 3:07pm
Interest rates
Bill Dudley: The Fed needs to get interest rates to a neutral setting, and that is probably 150-200 bps below where rates are presently set
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 07, 2024 10:36am
COSCIENS Biopharma Inc
About 9 months from the announcement of the proposed merger to its completion name change and change in the symbol for the stock. Now it looks like the new company will be launched over the
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 06, 2024 6:00pm
New Press Release - Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.
TORONTO, ONTARIO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ: AEZS) (TSX: AEZS) ("COSCIENS" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic...
read article.
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Aug 04, 2024 3:07am
RE:Current COVID wave: Immune booster anyone?
WHO recommends for immune booster diet - vegetables/fruits exercise hydration Regular sleep moderate alcohol reduce stress update vaccins
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 03, 2024 12:16pm
Current COVID wave: Immune booster anyone?
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 01, 2024 4:31pm
Biotech Bull Market: Goldman on interest rate cuts
"We now price 200bps of cuts though YE 2025, and over 75bps of cuts through the end of this year." - Goldman.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Aug 01, 2024 8:54am
β-glucan particles
Recognition of yeast β-glucan particles triggers immunometabolic signaling required for trained immunity Abstract Fungal β-glucans are major drivers of trained immunity which increases long
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 31, 2024 1:59pm
Potential synergies with the latest research
Perplexity Ai: Based on the complementary research on velocity and bioactivity, avenanthramides (AVE) and beta-glucan (BG) are likely to perform synergistically when used together, potentially
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 31, 2024 9:09am
RE:RE:RE:Angiogenesis Foundation Publishes Results
What these additional results were expected to achieve July 2023. That was before the merger which optimized the company to bring transformational products to market. Gilles has also talked about a
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden